Skip to main content

Zogenix Europe Ltd joins Birmingham Research Park

By News

Zogenix is committed to developing therapies that address specific clinical needs for people living with CNS and pain-related conditions who need innovative treatment alternatives to help them return to normal daily functioning.
Zogenix is committed to ensuring the safe and appropriate use of our products through industry-leading initiatives to educate patients, healthcare providers and pharmacists.
Innovation is key to our success. In 2010, we were honored to receive the Most Innovative Product Award in the Life Sciences category from CONNECT. We take pride in our approach to product development, commercialization strategy and delivering results.